Supriya Lifesci.

58
Hold
  • Market Cap: Small Cap
  • Industry: Pharmaceuticals & Biotechnology
  • ISIN: INE07RO01027
  • NSEID: SUPRIYA
  • BSEID: 543434
INR
744.85
-0.05 (-0.01%)
BSENSE

Dec 05

BSE+NSE Vol: 36.05 k

  • Price Points
  • Score
  • Mojo Parameters
  • Total Return
  • News and Corporate Actions
  • Key factors
  • Shareholding
  • Financials
  • CompanyCV
stock-recommendationProfit and Loss Results
Results Snapshot
Figures in Cr
Standalone - Profit And Loss Results
Mar'25
Mar'24
Mar'23
Mar'22
Mar'21
Mar'20
Profit And Loss Analysis Highlights
stock-summary

Net Sales

YoY Growth in year ended Mar 2025 is 22.12% vs 23.73% in Mar 2024

stock-summary

Operating Profit (PBDIT) excl Other Income

YoY Growth in year ended Mar 2025 is 50.77% vs 34.20% in Mar 2024

stock-summary

Interest

YoY Growth in year ended Mar 2025 is -20.09% vs -31.58% in Mar 2024

stock-summary

Profit After Tax

YoY Growth in year ended Mar 2025 is 57.80% vs 32.56% in Mar 2024

Compare Profit and Loss Results of Supriya Lifesci.
Markets Mojo
Figures in Cr
standalone - Profit And Loss Results
Markets Mojo
Markets Mojo
Change(INR)
Change(%)
No of Months
12
12
Operating Income
781.00
1,771.00
-990.00
-55.90%
Less :Inter divisional transfers
0.00
0.00
0.00
0%
Less: Excise
85.00
0.00
85.00
0%
Net Sales
696.00
1,771.00
-1,075.00
-60.70%
Expenditure (Ex Depriciation)
Stock Adjustments
-21.00
47.00
-68.00
-144.68%
Raw Materials Consumed
232.00
831.00
-599.00
-72.08%
Power & Fuel Cost
24.00
80.00
-56.00
-70.00%
Employee Cost
80.00
152.00
-72.00
-47.37%
Operating Expenses
50.00
118.00
-68.00
-57.63%
General and Administration Expenses
-1.00
-1.00
0.00
0.00%
Selling and Distribution Expenses
34.00
33.00
1.00
3.03%
Cost of Software developments
0.00
0.00
0.00
0%
Miscellaneous Expenses
12.00
25.00
-13.00
-52.00%
Expenses Capitalised
0.00
0.00
0.00
0%
Total Expenditure
435.00
1,344.00
-909.00
-67.63%
Operating Profit (PBDIT) excl Other Income
260.00
426.00
-166.00
-38.97%
Other Income
9.00
14.00
-5.00
-35.71%
Operating Profit (PBDIT)
270.00
441.00
-171.00
-38.78%
Interest
1.00
25.00
-24.00
-96.00%
Profit before Depriciation and Tax
268.00
415.00
-147.00
-35.42%
Depreciation
20.00
79.00
-59.00
-74.68%
Profit Before Taxation & Exceptional Items
248.00
336.00
-88.00
-26.19%
Exceptional Income / Expenses
0.00
0.00
0.00
0%
Profit Before Tax
248.00
336.00
-88.00
-26.19%
Provision for Tax
60.00
78.00
-18.00
-23.08%
Profit After Tax
187.00
257.00
-70.00
-27.24%
Extraordinary Items
0.00
0.00
0.00
0%
Adj to Profit After Tax
0.00
0.00
0.00
0%
Profit Balance B/F
600.00
1,042.00
-442.00
-42.42%
Profit Available for appropriations
788.00
1,299.00
-511.00
-39.34%
Appropriations
788.00
1,299.00
-511.00
-39.34%
Equity Dividend (%)
50%
100%
-50.00
Earnings Per Share
23.35
28.39
-5.04
-17.75%
Profit And Loss - Net Sales
Net Sales 696.49 Cr
in Mar 2025

Figures in Cr
stock-summary

YoY Growth in year ended Mar 2025 is 22.12% vs 23.73% in Mar 2024

Profit And Loss - Operating Profit (PBDIT)
Operating Profit (PBDIT) 260.80 Cr
in Mar 2025

Figures in Cr
stock-summary

YoY Growth in year ended Mar 2025 is 50.77% vs 34.20% in Mar 2024

Profit And Loss - Interest
Interest 1.69 Cr
in Mar 2025

Figures in Cr
stock-summary

YoY Growth in year ended Mar 2025 is -20.09% vs -31.58% in Mar 2024

Profit And Loss - Profit After Tax
Profit After Tax 187.96 Cr
in Mar 2025

Figures in Cr
stock-summary

YoY Growth in year ended Mar 2025 is 57.80% vs 32.56% in Mar 2024